Waters Corporation Common Equity (Total)

Common Equity (Total) of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including Common Equity (Total) growth rates and interactive chart.

Highlights and Quick Summary

  • Common Equity (Total) for the quarter ending December 30, 2020 was $232 Million (a -658.3% decrease compared to previous quarter)
  • Year-over-year quarterly Common Equity (Total) decreased by -168.68%
  • Annual Common Equity (Total) for 2020 was $232 Million (a -207.33% decrease from previous year)
  • Annual Common Equity (Total) for 2019 was $-216 Million (a -113.8% decrease from previous year)
  • Annual Common Equity (Total) for 2018 was $1.57 Billion (a -29.84% decrease from previous year)
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Common Equity (Total) of Waters Corporation

Most recent Common Equity (Total)of WAT including historical data for past 10 years.

Interactive Chart of Common Equity (Total) of Waters Corporation

Waters Corporation Common Equity (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $232.14 $-41.58 $-191.74 $-338.0 $232.14
2019 $-216.28 $115.5 $556.24 $967.74 $-216.28
2018 $1,567.26 $1,876.43 $1,975.09 $2,114.89 $1,567.26
2017 $2,233.79 $2,629.09 $2,518.64 $2,394.81 $2,233.79
2016 $2,301.95 $2,259.14 $2,149.34 $2,101.69 $2,301.95
2015 $2,058.85 $1,968.56 $1,932.6 $1,862.24 $2,058.85
2014 $1,894.67 $1,841.82 $1,843.49 $1,819.37 $1,894.67
2013 $1,763.17 $1,618.63 $1,520.11 $1,476.5 $1,763.17
2012 $1,467.36 $1,329.88 $1,262.68 $1,287.53 $1,467.36
2011 $1,226.58 $1,159.08 $1,225.53 $1,150.79 $1,226.58
2010 $1,068.8 $923.26 $812.95 $1,068.8

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.